AI in healthcare uses large amounts of patient information to learn and make decisions. This data includes protected health information (PHI) stored in electronic health records (EHRs), diagnostic images, clinical notes, and information from wearable devices. AI can analyze this data faster than humans and find new health insights. But there are several problems in using this data safely.<\/p>\n
Most AI healthcare technologies start as academic research but are usually turned into products by private companies. This change brings conflicts between patient privacy and company profits. These companies often use large patient datasets to develop products and train AI continuously. Public\u2013private partnerships, like Google DeepMind\u2019s work with the Royal Free London NHS Foundation Trust, received criticism in the U.K. for not getting proper patient consent or legal permission to use data. Similar concerns exist in the U.S., where hospitals may share data with companies like Microsoft or IBM.<\/p>\n
This private control of patient data can threaten patient privacy. A 2018 survey found only 11% of American adults were willing to share their health data with tech companies, while 72% trusted doctors. People worry that companies might sell or misuse their data.<\/p>\n
AI algorithms are often called a “black box” because no one fully understands how the AI makes decisions. This makes it hard for doctors to trust or explain AI results. The lack of clear process also makes regulation and informed consent difficult. Patients and doctors cannot easily check how patient data affects AI decisions. This raises risks like bias, mistakes, or unauthorized use of data.<\/p>\n
Because AI systems change over time with new data, they need new ways of oversight. Regular monitoring is needed to keep patient privacy and safety.<\/p>\n
Before, removing personal details from patient data was a key way to protect privacy. It was thought this would stop data from being linked back to patients. But new AI methods and data sharing can bring re-identification risks.<\/p>\n
One study found an AI could identify 85.6% of adults and 69.8% of children in a physical activity group, even with personal details removed. Another case showed ancestry data could identify about 60% of Americans of European descent. These examples show anonymization alone is not enough to protect privacy and raise ethical questions about sharing patient data.<\/p>\n
Many AI providers store patient data on cloud servers outside the United States. When data crosses borders, it faces different legal rules, making privacy protections harder. For example, Google DeepMind moved control of NHS patient data from the UK to servers in the U.S. This raised questions about following different data laws.<\/p>\n
In the U.S., hospitals must follow HIPAA rules. But HIPAA does not fully cover AI data use or international data transfer. Healthcare groups must carefully check contracts with AI vendors to ensure data stays in proper locations and follows laws.<\/p>\n
<\/p>\n